UK gene therapy biotech Nightstar Therapeutics sets terms for $75 million IPO – Nasdaq
Nasdaq |
UK gene therapy biotech Nightstar Therapeutics sets terms for $75 million IPO
Nasdaq Nightstar Therapeutics, a UK biotech developing gene therapies for rare retinal diseases, announced terms for its IPO on Friday. The London, United Kingdom-based company plans to raise $75 million by offering 5.4 million shares at a price range of $13 … |
